Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study

Massimo Federico, Stefano Luminari, Cinzia Pellegrini, Francesco Merli, Emanuela Anna Pesce, Stephane Chauvie, Letizia Gandolfi, Isabella Capodanno, Massimiliano Salati, Lisa Argnani, Pier Luigi Zinzani

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e139-e141
Number of pages3
JournalHaematologica
Volume101
Issue number4
DOIs
Publication statusPublished - Mar 31 2016

Keywords

  • ABVD
  • Brentuximab vedotin
  • Early
  • Hodgkin lymphoma
  • Intermediate
  • Radiotherapy
  • Toxicity

ASJC Scopus subject areas

  • Hematology

Cite this

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma : Final results of a pilot phase II study. / Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi.

In: Haematologica, Vol. 101, No. 4, 31.03.2016, p. e139-e141.

Research output: Contribution to journalArticle

Federico, M, Luminari, S, Pellegrini, C, Merli, F, Pesce, EA, Chauvie, S, Gandolfi, L, Capodanno, I, Salati, M, Argnani, L & Zinzani, PL 2016, 'Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study', Haematologica, vol. 101, no. 4, pp. e139-e141. https://doi.org/10.3324/haematol.2015.138388
Federico, Massimo ; Luminari, Stefano ; Pellegrini, Cinzia ; Merli, Francesco ; Pesce, Emanuela Anna ; Chauvie, Stephane ; Gandolfi, Letizia ; Capodanno, Isabella ; Salati, Massimiliano ; Argnani, Lisa ; Zinzani, Pier Luigi. / Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma : Final results of a pilot phase II study. In: Haematologica. 2016 ; Vol. 101, No. 4. pp. e139-e141.
@article{ee52b63123f6417f912039516159d293,
title = "Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study",
keywords = "ABVD, Brentuximab vedotin, Early, Hodgkin lymphoma, Intermediate, Radiotherapy, Toxicity",
author = "Massimo Federico and Stefano Luminari and Cinzia Pellegrini and Francesco Merli and Pesce, {Emanuela Anna} and Stephane Chauvie and Letizia Gandolfi and Isabella Capodanno and Massimiliano Salati and Lisa Argnani and Zinzani, {Pier Luigi}",
year = "2016",
month = "3",
day = "31",
doi = "10.3324/haematol.2015.138388",
language = "English",
volume = "101",
pages = "e139--e141",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "4",

}

TY - JOUR

T1 - Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma

T2 - Final results of a pilot phase II study

AU - Federico, Massimo

AU - Luminari, Stefano

AU - Pellegrini, Cinzia

AU - Merli, Francesco

AU - Pesce, Emanuela Anna

AU - Chauvie, Stephane

AU - Gandolfi, Letizia

AU - Capodanno, Isabella

AU - Salati, Massimiliano

AU - Argnani, Lisa

AU - Zinzani, Pier Luigi

PY - 2016/3/31

Y1 - 2016/3/31

KW - ABVD

KW - Brentuximab vedotin

KW - Early

KW - Hodgkin lymphoma

KW - Intermediate

KW - Radiotherapy

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=84962343919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962343919&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.138388

DO - 10.3324/haematol.2015.138388

M3 - Article

AN - SCOPUS:84962343919

VL - 101

SP - e139-e141

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -